[ad_1]
NEW YORK, March 13, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NRx Pharmaceuticals, Inc. NRXP NRXPW))) between June 1, 2021 and November 4, 2021, inclusive (the “Class Period”), of the important March 21, 2022 lead plaintiff deadline.
SO WHAT: If you purchased NRx securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
[WATCH NOW] Chris Capre, former hedge fund trader, teaches you how to trade options like a pro in even the most volatile markets. Click Here to Watch on YouTube!
WHAT TO DO NEXT: To join the NRx class action, go to https://rosenlegal.com/submit-form/?case_id=3121 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 21, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017….
[ad_2]
